Design and Construction of Short Synthetic Terminators for Β-Amyrin Production in Saccharomyces Cerevisiae
Muhammad Saad Ahmed,Sana Ikram,Aamir Rasool,Chun Li
DOI: https://doi.org/10.1016/j.bej.2019.03.011
IF: 3.9
2019-01-01
Biochemical Engineering Journal
Abstract:The coupled employment of synthetic biology and metabolic engineering strategies is prolific for the optimized production of value-added compounds. Terminators are the prime components in the "expression cassettes" that influence the net protein production. Herein, beta-amyrin is overproduced in Saccharomyces cerevisiae through optimizing the pathway expression by the employment of SST (Short Synthetic Terminators). Initially, the beta AS gene was expressed with P-TEF1 promoter along-with T-CYC1 terminator and produced 2.7 mg L-1 beta-amyrin. The precursor's supply was enhanced through overexpressing the key regulatory genes of terpenoid pathway i.e. ERG1, ERG9, ERG20, IDI, tHMG1 controlled by constitutive promoters P-ERG1, P-TPI1, P-TDH3, P-FBA1, P-PGK1 that enhanced 3.8-fold beta-amyrin production compared with the control strain. Moreover, a set of 23 SST was designed by analyzing the native terminator sequences and characterized, where, Syn(TER10), Syn(TER9), Syn(TER8), Syn(TER8), Syn(TER22), and Syn(TER19), terminators showed 5.57-, 5.04-, 3.55-, 3.40-, 1.89-, and 1.71-fold, enhanced expression of EGFP compared with native T-CYC1 terminator. Subsequently, aforesaid strong SST was employed to optimize the expression of the beta-amyrin pathway, which increased 3.16-fold production of beta-amyrin. However, after optimization of the beta-amyrin pathway, the engineered strain enhanced 12.14-fold (32.8 mg L-1) of beta-amyrin production. Finally, using the 5 L fermenter, the production of beta-amyrin was 108.26 mgL(-1) which were 40-fold higher and that of ergosterol was 38.8 mgL(-1), 6.80-fold higher comparative to the GSK1 strain.